Monaco Asset Management SAM

Position in FATE — Fate Therapeutics Inc

CIK 1803593 Monaco, O9

Position in FATE

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$972,000

+$158,600 QoQ

Shares Held

810,000

-2.4% QoQ

Ownership

0.676%

of shares outstanding

% of Portfolio

0.31%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Monaco Asset Management SAM holds $49,930,003 across 9 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	MRVI	Maravai Lifesciences Holdings, Inc.	2,231,026	$13,921,602
2	BMRN	Biomarin Pharmaceutical Inc	184,937	$10,582,095
3	RCKT	Rocket Pharmaceuticals, Inc.	2,480,468	$8,483,200
4	NKTX	Nkarta, Inc.	2,373,400	$6,716,722
5	NVAX	Novavax Inc	577,464	$5,439,710
6	PLRX	Pliant Therapeutics, Inc.	1,938,747	$2,210,171
7	VNDA	Vanda Pharmaceuticals Inc.	221,286	$1,354,270
8	LKFT	Lakefront Biotherapeutics NV	25,600	$767,488

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$972,000	810,000	-2.4%	Shares	Sole	2026-05-11
2025-12-31	$813,400	830,000	+7.8%	Shares	Sole	2026-02-10
2025-09-30	$970,200	770,000	+14.1%	Shares	Sole	2025-11-10
2025-06-30	$756,000	675,000	-41.3%	Shares	Sole	2025-08-07
2025-03-31	$908,269	1,149,708	+250.9%	Shares	Sole	2025-05-08
2024-12-31	$540,657	327,671	+138.0%	Shares	Sole	2025-02-10
2024-09-30	$481,848	137,671	-52.0%	Shares	Sole	2024-11-07
2024-06-30	$941,032	286,900	-9.4%	Shares	Sole	2024-08-07
2024-03-31	$2,325,348	316,805	-85.5%	Shares	Sole	2024-05-09
2023-12-31	$8,165,272	2,183,228	+18.1%	Shares	Sole	2024-02-07
2023-09-30	$3,917,641	1,847,944	+83.8%	Shares	Sole	2023-11-07
2023-06-30	$4,784,875	1,005,226	+3.6%	Shares	Sole	2023-08-08
2023-03-31	$5,530,670	970,293	+288.1%	Shares	Sole	2023-05-11
2022-12-31	$2,522,500	250,000	—	Shares	Sole	2023-02-03
No filing history on record for this holder in this stock.